It can be speculated that KL-6 has a crucial role as a key molecule involved in epithelial-mesenchymal interactions, though the pathogenetic pathways involved in serum KL-6 increase are unknown as well as KL-6’s prognostic and predictive role as biomarker in COVID-19 patients. This evidence concerns the gene MUC1 and COVID-19.